77 is the total number of securities Frazier Life Sciences Management, L.P. has owned. The longest Frazier Life Sciences Management, L.P. has owned a single stock is 7 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| ARQT | ARCUTIS BIOTHERAPEUTIC... | 7 | 7 | 3.06% | 9.50% | 16.96% | Q1 2022 | Q3 2023 | 7 |
| MIRM | MIRUM PHARMACEUTICALS INC | 7 | 7 | 4.68% | 7.31% | 13.58% | Q1 2022 | Q3 2023 | 7 |
| PHAT | PHATHOM PHARMACEUTICAL... | 7 | 7 | 4.35% | 6.34% | 8.64% | Q1 2022 | Q3 2023 | 7 |
| KRYS | KRYSTAL BIOTECH INC | 7 | 7 | 4.91% | 6.02% | 7.62% | Q1 2022 | Q3 2023 | 7 |
| SNDX | SYNDAX PHARMACEUTICALS... | 7 | 7 | 0.58% | 4.80% | 6.32% | Q1 2022 | Q3 2023 | 7 |
| PCVX | VAXCYTE INC | 7 | 7 | 2.86% | 3.81% | 4.75% | Q1 2022 | Q3 2023 | 7 |
| CRNX | CRINETICS PHARMACEUTIC... | 7 | 7 | 1.52% | 2.17% | 3.14% | Q1 2022 | Q3 2023 | 7 |
| ALPN | ALPINE IMMUNE SCIENCES... | 7 | 7 | 1.36% | 2.06% | 3.20% | Q1 2022 | Q3 2023 | 7 |
| TARS | TARSUS PHARMACEUTICALS... | 7 | 7 | 1.63% | 2.02% | 2.46% | Q1 2022 | Q3 2023 | 7 |
| KALV | KALVISTA PHARMACEUTICA... | 7 | 7 | 1.36% | 1.74% | 2.07% | Q1 2022 | Q3 2023 | 7 |
| COGT | COGENT BIOSCIENCES INC | 7 | 7 | 0.97% | 1.59% | 2.38% | Q1 2022 | Q3 2023 | 7 |
| ANAB | ANAPTYSBIO INC | 7 | 7 | 1.07% | 1.53% | 1.90% | Q1 2022 | Q3 2023 | 7 |
| MRUS | MERUS N V | 7 | 7 | 0.72% | 1.15% | 1.44% | Q1 2022 | Q3 2023 | 7 |
| TYRA BIOSCIENCES INC | 7 | 7 | 0.63% | 1.04% | 1.65% | Q1 2022 | Q3 2023 | 7 | |
| REPL | REPLIMUNE GROUP INC | 7 | 7 | 0.44% | 0.98% | 1.58% | Q1 2022 | Q3 2023 | 7 |
| GRTS | GRITSTONE BIO INC | 7 | 7 | 0.16% | 0.95% | 1.84% | Q1 2022 | Q3 2023 | 7 |
| ARVN | ARVINAS INC | 7 | 7 | 0.37% | 0.80% | 1.55% | Q1 2022 | Q3 2023 | 7 |
| SLN | SILENCE THERAPEUTICS PLC | 7 | 7 | 0.29% | 0.74% | 1.43% | Q1 2022 | Q3 2023 | 7 |
| NTLA | INTELLIA THERAPEUTICS INC | 7 | 7 | 0.43% | 0.72% | 1.26% | Q1 2022 | Q3 2023 | 7 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 7 | 7 | 0.44% | 0.72% | 1.33% | Q1 2022 | Q3 2023 | 7 |
| STRO | SUTRO BIOPHARMA INC | 7 | 7 | 0.18% | 0.68% | 1.24% | Q1 2022 | Q3 2023 | 7 |
| CERE | CEREVEL THERAPEUTICS H... | 7 | 7 | 0.17% | 0.62% | 0.86% | Q1 2022 | Q3 2023 | 7 |
| PASG | PASSAGE BIO INC | 7 | 7 | 0.08% | 0.51% | 1.32% | Q1 2022 | Q3 2023 | 7 |
| ACRS | ACLARIS THERAPEUTICS INC | 7 | 7 | 0.12% | 0.34% | 0.60% | Q1 2022 | Q3 2023 | 7 |
| HILLEVAX INC | 6 | 6 | 8.74% | 10.51% | 12.84% | Q2 2022 | Q3 2023 | 6 | |
| KDNY | CHINOOK THERAPEUTICS INC | 6 | 6 | 3.78% | 6.75% | 9.97% | Q1 2022 | Q2 2023 | 6 |
| TRVI | TREVI THERAPEUTICS INC | 6 | 6 | 0.31% | 0.77% | 1.00% | Q2 2022 | Q3 2023 | 6 |
| IMVT | IMMUNOVANT INC | 6 | 6 | 0.22% | 0.40% | 0.66% | Q1 2022 | Q2 2023 | 6 |
| VRNA | VERONA PHARMA PLC | 5 | 5 | 1.65% | 3.50% | 4.57% | Q3 2022 | Q3 2023 | 5 |
| RYTM | RHYTHM PHARMACEUTICALS... | 5 | 5 | 2.13% | 3.11% | 3.61% | Q3 2022 | Q3 2023 | 5 |
| ACAD | ACADIA PHARMACEUTICALS... | 5 | 5 | 0.85% | 1.04% | 1.23% | Q3 2022 | Q3 2023 | 5 |
| BLUE | BLUEBIRD BIO INC | 5 | 5 | 0.33% | 0.47% | 0.70% | Q3 2022 | Q3 2023 | 5 |
| NEWAMSTERDAM PHARMA CO... | 4 | 4 | 6.33% | 7.65% | 9.09% | Q4 2022 | Q3 2023 | 4 | |
| IMAGO BIOSCIENCES INC | 4 | 4 | 3.44% | 5.25% | 8.91% | Q1 2022 | Q4 2022 | 4 | |
| THESEUS PHARMACEUTICAL... | 4 | 4 | 0.40% | 0.88% | 1.44% | Q4 2022 | Q3 2023 | 4 | |
| MGNX | MACROGENICS INC | 3 | 1 | 0.19% | 0.55% | 0.88% | Q3 2022 | Q3 2023 | 4 |
| PRTA | PROTHENA CORP PLC | 4 | 4 | 0.41% | 0.46% | 0.52% | Q4 2022 | Q3 2023 | 4 |
| EPIX | ESSA PHARMA INC | 4 | 4 | 0.10% | 0.19% | 0.36% | Q1 2022 | Q4 2022 | 4 |
| APTX | APTINYX INC | 4 | 4 | 0.03% | 0.14% | 0.36% | Q1 2022 | Q4 2022 | 4 |
| NEWAMSTERDAM PHARMA CO... | 4 | 4 | 0.03% | 0.05% | 0.07% | Q4 2022 | Q3 2023 | 4 | |
| BBIO | BRIDGEBIO PHARMA INC | 3 | 3 | 1.41% | 2.74% | 4.77% | Q1 2023 | Q3 2023 | 3 |
| TCDA | TRICIDA INC | 3 | 3 | 1.46% | 1.81% | 2.06% | Q1 2022 | Q3 2022 | 3 |
| ALLK | ALLAKOS INC | 3 | 3 | 0.36% | 1.71% | 2.51% | Q3 2022 | Q1 2023 | 3 |
| RVMD | REVOLUTION MEDICINES INC | 3 | 3 | 1.34% | 1.51% | 1.83% | Q1 2023 | Q3 2023 | 3 |
| FLACU | FRAZIER LIFESCIENCES A... | 3 | 3 | 1.17% | 1.28% | 1.40% | Q1 2022 | Q3 2022 | 3 |
| ENLIVEN THERAPEUTICS INC | 3 | 3 | 0.95% | 1.09% | 1.32% | Q1 2023 | Q3 2023 | 3 | |
| GRCL | GRACELL BIOTECHNOLOGIE... | 3 | 3 | 0.68% | 1.01% | 1.62% | Q1 2022 | Q3 2022 | 3 |
| AVTE | AEROVATE THERAPEUTICS INC | 3 | 3 | 0.49% | 0.87% | 1.09% | Q1 2023 | Q3 2023 | 3 |
| PARDES BIOSCIENCES INC | 3 | 3 | 0.12% | 0.55% | 1.28% | Q1 2022 | Q3 2022 | 3 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 3 | 3 | 0.32% | 0.33% | 0.35% | Q1 2023 | Q3 2023 | 3 |
| MTEM | MOLECULAR TEMPLATES INC | 3 | 3 | 0.08% | 0.20% | 0.40% | Q1 2022 | Q3 2022 | 3 |
| ADCT | ADC THERAPEUTICS SA | 3 | 3 | 0.10% | 0.18% | 0.23% | Q1 2023 | Q3 2023 | 3 |
| NABRIVA THERAPEUTICS PLC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q3 2022 | Q1 2023 | 3 | |
| SRRA | SIERRA ONCOLOGY INC | 2 | 2 | 4.52% | 5.46% | 6.40% | Q1 2022 | Q2 2022 | 2 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2 | 2 | 1.07% | 1.91% | 2.74% | Q1 2022 | Q2 2022 | 2 |
| DISC MEDICINE INC | 2 | 2 | 1.74% | 1.89% | 2.04% | Q2 2023 | Q3 2023 | 2 | |
| ISEE | IVERIC BIO INC | 2 | 2 | 0.15% | 1.81% | 3.47% | Q1 2022 | Q2 2022 | 2 |
| ORIC | ORIC PHARMACEUTICALS INC | 2 | 2 | 0.86% | 0.93% | 0.99% | Q2 2023 | Q3 2023 | 2 |
| VECT | VECTIVBIO HLDG AG | 2 | 2 | 0.71% | 0.78% | 0.84% | Q4 2022 | Q1 2023 | 2 |
| MORF | MORPHIC HLDG INC | 2 | 2 | 0.58% | 0.75% | 0.91% | Q1 2023 | Q2 2023 | 2 |
| RNA | AVIDITY BIOSCIENCES INC | 2 | 2 | 0.56% | 0.62% | 0.69% | Q4 2022 | Q1 2023 | 2 |
| ZYMEWORKS INC | 2 | 2 | 0.30% | 0.35% | 0.40% | Q4 2022 | Q1 2023 | 2 | |
| DCPH | DECIPHERA PHARMACEUTIC... | 2 | 2 | 0.31% | 0.31% | 0.31% | Q2 2023 | Q3 2023 | 2 |
| EPZM | EPIZYME INC | 2 | 2 | 0.07% | 0.09% | 0.10% | Q1 2022 | Q2 2022 | 2 |
| NABRIVA THERAPEUTICS PLC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q1 2022 | Q2 2022 | 2 | |
| BCYC | BICYCLE THERAPEUTICS PLC | 1 | 1 | 2.26% | 2.26% | 2.26% | Q1 2022 | Q1 2022 | 1 |
| RCKT | ROCKET PHARMACEUTICALS... | 1 | 1 | 1.91% | 1.91% | 1.91% | Q3 2023 | Q3 2023 | 1 |
| APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 1.55% | 1.55% | 1.55% | Q3 2023 | Q3 2023 | 1 |
| AN2 THERAPEUTICS INC | 1 | 1 | 1.48% | 1.48% | 1.48% | Q3 2023 | Q3 2023 | 1 | |
| SVRA | SAVARA INC | 1 | 1 | 1.00% | 1.00% | 1.00% | Q3 2023 | Q3 2023 | 1 |
| SOLENO THERAPEUTICS INC | 1 | 1 | 0.91% | 0.91% | 0.91% | Q3 2023 | Q3 2023 | 1 | |
| RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q2 2023 | Q2 2023 | 1 |
| APOGEE THERAPEUTICS INC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q3 2023 | Q3 2023 | 1 | |
| AVDL | AVADEL PHARMACEUTICALS... | 1 | 1 | 0.55% | 0.55% | 0.55% | Q1 2022 | Q1 2022 | 1 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2023 | Q3 2023 | 1 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1 | 1 | 0.17% | 0.17% | 0.17% | Q1 2022 | Q1 2022 | 1 |
| SNDX | SYNDAX PHARMACEUTICALS... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2023 | Q3 2023 | 1 |
Download | |||||||||
The securities at the top of the list , including ARCUTIS BIOTHERAPEUTICS INC, MIRUM PHARMACEUTICALS INC, and PHATHOM PHARMACEUTICALS INC, are the highest-conviction holdings of Frazier Life Sciences Management, L.P..
The conviction is calculated by counting the number of quarters a security has been reported by Frazier Life Sciences Management, L.P.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Frazier Life Sciences Management, L.P. owns currently or has owned in the past.